HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LQDA
Liquidia Corporation
There isn't enough reported data to score LQDA yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LQDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Strong |
LQDA's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LQDA PE Valuation
LQDA has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LQDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for LQDA, but weaker profitability. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LQDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.15 | — |
| Q3 2026 | -$1.20 | +$0.23 |
| Q2 2026 | $1.40 | +$3.09 |
| Q1 2026 | $0.17 | +$1.74 |
| Q4 2025 | -$0.80 | +$0.86 |
| Q3 2025 | -$1.43 | +$0.21 |
| Q2 2025 | -$1.69 | -$0.11 |
| Q1 2025 | -$1.57 | $0.00 |
| Q4 2024 | -$1.66 | -$0.45 |
LQDA has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over LQDA on profitability, with a higher operating margin.
LQDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $225.3M | +315% |
| Q2 2026 | $171.7M | +1843% |
| Q1 2026 | $132.9M | +4158% |
| Q4 2025 | $92M | +3055% |
| Q3 2025 | $54.3M | +1122% |
| Q2 2025 | $8.8M | +142% |
| Q1 2025 | $3.1M | +5% |
| Q4 2024 | $2.9M | -36% |
LQDA's revenue has grown year over year for seven quarters in a row: $225M last quarter, up 315% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -117% | -120 points |
| Q2 2026 | 50% | +474 points |
| Q1 2026 | 46% | +1182 points |
| Q4 2025 | 22% | +1259 points |
| Q3 2025 | 3.3% | +660 points |
| Q2 2025 | -424% | +319 points |
| Q1 2025 | -1135% | -166 points |
| Q4 2024 | -1238% | -654 points |
LQDA's operating margin was −117% last quarter, down 120 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LQDA on cash flow, with more consistent year-over-year improvement.
LQDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $129.8M | +$140.5M |
| Q2 2026 | $69M | +$109.5M |
| Q1 2026 | $50.2M | +$81.2M |
| Q4 2025 | $42.2M | +$64.3M |
| Q3 2025 | -$10.7M | +$16.1M |
| Q2 2025 | -$40.5M | -$16.6M |
| Q1 2025 | -$31M | -$5.5M |
| Q4 2024 | -$22.1M | -$5.9M |
LQDA's free cash flow has turned positive after six years mostly in the red: $291M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LQDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LQDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -11.9M shares |
| 1 year | +3.7% | +3.2M shares |
| 3 years | +38% | +24.7M shares |
| 5 years | +72% | +37.4M shares |
| Available history | +340% | +69.2M shares |
LQDA has 90M diluted shares, up 3.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has the edge over LQDA on leverage, with a lower net debt burden relative to earnings.
LQDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -4.8x | Net Cash |
LQDA has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LQDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 37.7 | Neutral |
LQDA's weekly RSI is 52 (neutral) and its Stochastic is 38 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LQDA PE vs Healthcare Sector
| Metric | LQDA | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 26x | 23% above |
| PE % | 16 | 29 | 13 pts below |
LQDA has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LQDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.6 | 33% above |
| 20 week MA | $63.0 | 7.7% below |
| 50 week MA | $51.4 | 13% above |
| 100 week MA | $34.9 | 67% above |
| 200 week MA | $22.3 | 160% above |
LQDA has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LQDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.94 | $2.82 | -43% |
| 2021 | $2.82 | $4.67 | +66% |
| 2022 | $4.67 | $6.17 | +32% |
| 2023 | $6.17 | $12.0 | +95% |
| 2024 | $12.0 | $11.6 | -3.8% |
| 2025 | $11.6 | $34.4 | +197% |
| 2026 YTD | $34.4 | $58.1 | +69% |
LQDA has the edge over HIMS on returns for 2026, with the stronger performance.